Consultation with the Specialist

1996 ◽  
Vol 17 (9) ◽  
pp. 323-326
Author(s):  
Laurel K. Leslie ◽  
W. Thomas Boyce

Historical Perspective In 1964, Green and Solnit first described a constellation of clinical features comprising a "vulnerable child syndrome" based on a cohort of 25 families. Each of the families had a child who had suffered a life-threatening illness in infancy. The authors observed that the parents, particularly the mothers, shared a continuing and unfounded anxiety concerning their children's health. Green and Solnit hypothesized that the parents persisted in fearing that their child was destined to die in childhood. The parents' perception of their child as uniquely vulnerable led to myriad maladaptive behaviors and difficulties in parent-child interactions (Tables 1 and 2). The parents overprotected the child, were unable to set age-appropriate limits, and displayed excessive concerns in medical settings about their children's health. The children, responding to their parents' expectations of vulnerability, evidenced exaggerated separation anxiety, out-of-control behavior, school underachievement, and distorted perceptions of their own health. Interestingly, these behaviors were not noted in the parents' interaction with their other children. As clinicians began to identify families that had this constellation of clinical features, additional details about the vulnerable child syndrome were elucidated. Parental perception of their child as medically vulnerable was not a universal legacy of severe illness in infancy, but more likely a reflection of how an individual family responded to an illness in their child.

PEDIATRICS ◽  
1987 ◽  
Vol 79 (4) ◽  
pp. 637-639
Author(s):  
DEBORAH L. CALLANAN ◽  
LINDA B. HINER

Parental actions and beliefs shape every aspect of a child's health and development. Green and Solnit described a vulnerable child syndrome in which the child's development was impaired when the parents treated him or her in an inappropriate fashion because they had an unreasonable expectation that he or she would die. We recently cared for a child who suffered a life-threatening event (status epilepticus due to hyponatremia) because the parents were trying to avoid reproducing a serious, but not life-threatening, problem (nursing bottle caries) that had occurred in the older sibling. This distortion of professional advice created vulnerability to significant neurologic problems.


Author(s):  
Mohiuddin Ahmed Khan ◽  
Mafruha Akter

As no specific standard therapies have been approved for Coronavirus disease 2019 (COVID-19), so prevention and supportive care dominate the approach to COVID-19. Exposure to this severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) results in an adaptive immune response that commonly include antibodies with neutralization activity. Treatments directly targeting the virus and the inflammatory response to it remain investigational. Convalescent plasma (CP) is such a therapy that had been reported hundred years back in studies from the Spanish influenza era. So the idea of convalescent plasma from subjects who have recovered from viral infections has been used to both prevent or treat disease. Over the past two decades’ notable examples of the successful use of convalescent plasma (CP) include influenza, measles, Middle East respiratory syndrome (MERS), Ebola and severe acute respiratory syndrome (SARS). Two case series were recently published by China examining the therapeutic use of CP in patients with COVID-19. In the context of pandemic situation, the Food and Drug Administration (FDA) allowed to use COVID-19 convalescent plasma as Investigational New Drug (IND) since April 2020 to help patients with serious or immediately life-threatening illness associated with COVID- 19. Case series studying convalescent plasma use in the treatment of COVID-19 have been promising, but additional, high-quality studies are needed to determine the efficacy of the treatment when applied for prophylaxis, for early phases of illness and for severe illness. Bangladesh also started program to use convalescent plasma for severe and critical COVID-19 patients under limited clinical trial. J Bangladesh Coll Phys Surg 2020; 38(0): 109-115


2019 ◽  
Vol 32 (2) ◽  
pp. 148-152
Author(s):  
Steven L. Baumann ◽  
Dhaneesha Bahadur ◽  
Kathleen Begonia

The purpose of this paper is to explore how people from diverse backgrounds and places, who are severely ill, disabled, or facing death, use art to help themselves and others not only make sense of such experiences but live fully with loss and the limited time remaining. The humanbecoming paradigm is used to provide a language to talk about Western and non-Western experiences of life-threatening illness, disability and death, and art. The persons discussed in the paper suggest that age and place, although influences, are not particularly relevant, nor is severe illness, even those associated with significant failing capacities, because they cannot contain the human spirit or relationships.


PEDIATRICS ◽  
1964 ◽  
Vol 34 (1) ◽  
pp. 58-66
Author(s):  
Morris Green ◽  
Albert J. Solnit

1. A group of clinical features constituting a vulnerable child syndrome is reported and described in 25 children with a history of an illness or accident from which they recovered although the parents were expecting a fatal outcome. 2. This paper describes a study of this group based on the hypothesis that children who are expected by their parents to die prematurely often react with a disturbance in psychosocial development and in the parent-child relationship. 3. Outstanding clinical features include difficulty with separation, infantile behavior, bodily overconcerns, and school underachievement. 4. Predisposing factors and determinants of the symptomatology are discussed along with suggestions for management and prevention.


2020 ◽  
Vol 7 (3) ◽  
pp. 508-516
Author(s):  
Sahar Sadjadi

Abstract A recent spate of legislation such as South Dakota's HB 1057, known as the Vulnerable Child Protection Act, seeks to criminalize medical treatment for gender transition in minors under sixteen. This essay argues that these laws do not safeguard children's health but are part of a broader attack on transgender rights that uses the protection of children as a powerful pretense to scapegoat a minority. It suggests that the analyses and insights of the field of transgender studies could inform, enrich, and reconfigure current clinical and public-policy debates around gender-variant children. This essay also aims at drawing the attention of supporters of transgender children to aspects of current medical treatments and their potential implications for young people that might get lost in this explosive political climate.


2007 ◽  
Vol 41 (6) ◽  
pp. 28
Author(s):  
ROXANNE NELSON

1987 ◽  
Vol 32 (10) ◽  
pp. 906-906
Author(s):  
No authorship indicated

Sign in / Sign up

Export Citation Format

Share Document